Good evening,

Virgin Australia's board has retained control of the airline, but there's plenty of jostling among those keen to get their hands on the keys.

For advisers, it's the biggest ticket in town. Bankers, lawyers, accountants, insolvency types, you name it - Virgin is priority No.1.

Tonight, Street Talk can reveal one of the juicier mandates. It's one that has two of the biggest players in Australian dealmaking working side by side and, while it's only early days, they're sure to keep the situation interesting, should it open up for them.

Elsewhere, we look at the infrastructure funds taking a close look at Healthscope's pathology unit- yep, infrastructure considering a pathology acquisition - as well as raising candidate Challenger and copper play IGO.

Happy reading,

Sarah Thompson, Anthony Macdonald and Tim Boyd

Street Talk Editors